These stocks are likely to be in focus on May 20

These stocks are likely to be in focus on May 20

by 5paisa Research Team Last Updated: 2022-05-19T18:04:05+05:30

At market close on Thursday, the Sensex fell sharply and was down by 1416.30 points or 2.61% and at 52.792.23 level and the Nifty 50 was trading at 15,8409.40 down by 430.90 points or 2.65%. 

A total of 3447shares were traded on the BSE, out of which 779 shares have advanced, 2557 shares have declined and 111 shares are unchanged.

The top trending stocks on the BSE were Amber Enterprises, ITC, Caplin Labs, Dabur India, JK Lakshmi Cements, Lupin, TCS, Mannapuram Finance, and Dr Reddy’s Laboratories.

These stocks are likely to be in focus for Friday's trading session -

Mahindra & Mahindra Limited: Volkswagen and Mahindra & Mahindra (M&M) announced today that they have signed a Partnering Agreement to evaluate the scope of collaboration. They are exploring the use of MEB (Modular electric drive matrix) electric components for Mahindra's new “Born Electric” Platform. Mahindra intends to equip its Born Electric Platform with MEB electric components such as electric motors, battery system components and battery cells. It evaluates the scope of collaboration - it indicates binding rules for the evaluation phase as well as the non-binding scope of supply. The shares of M&M ended lower by 3.30%, on the BSE.

Dr Reddy’s Laboratories Limited:  The company's consolidated net profit for the quarter ended March 2022 dropped by 75.85% to Rs 87.5 crore, compared with Rs 362.4 crore in the same quarter last year. The profit figure was sharply lower compared with an ET Now analysts’ poll projection of Rs 560 crore. Revenue for the quarter rose 14.98% to Rs 5,436.8 crore from Rs 4,728.4 crore in the corresponding period last year. The scrip of Dr Reddy’s ended 0.82% higher, at Rs 3940 on the BSE.

JK Lakshmi Cements Limited: The shares of JK Lakshmi Cements surged almost 10% on the BSE today. The scrip was trading at Rs 448, in the morning after the company announced its financial results for its quarter ended on March 31, 2022. The net sales of the company rose by 12.32% and were reported at Rs 1599.83 crores compared to the net sales of Rs 1424.32 crores for the Q4FY21. The operating profit remained fairly unchanged at Rs 340.51 crore for Q4FY22. The net profit grew and was at Rs 188.38 crore an increase by 18 .39% in Q4FY22 as compared to the net profit of Rs 159.12 crore for the same quarter last year. At the day end, the scrip of the company was at Rs 422.15, up by 7.20% on the BSE.


Start Investing in 5 mins*

Get Benefits worth 2100* | Rs. 20 Flat Per Order | 0% Brokerage

About the Author

Our research team is composed of some highly qualified research professionals, their expertise range across sectors.

Disclaimer

Investment/Trading in securities Market is subject to market risk, past performance is not a guarantee of future performance. The risk of loss in trading and investment in Securities markets including Equites and Derivatives can be substantial.

Open Free Demat Account

& get benefits worth 2100*

Resend OTP
Please Enter OTP
  • Have Promo code?
  • Use code ACT2100
Enter Promo code
Account belongs to

By proceeding, you agree to the T&C.

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number